EVALUATION OF HEPATO - PROTECTIVE ACTIVITY OF K-LIV DS ON CARBON TETRACHLORIDE INDUCED HEPATOTOXICITY IN RATS
Dilpesh P. Jain, K. Chainani
Abstract
Dilpesh P. Jain, K. Chainani
Abstract
Present study investigates K-Liv DS, a polyherbal formulation on carbon tetrachloride induced hepatotoxicity in Wistar rats. Rats were divided into normal control, CCl4 control, CCl4+K-Liv DS (0.5 ml) and CCl4+K-LivDS (1 mL). CCl4 was injected intraperitoneally from day 1 to day 10, while K Liv DS was administered orally for 14 days. Hepatoprotective activity was assessed by estimating transaminases, alkaline phosphatase, total protein and bilirubin in serum. Estimation of oxidative stress markers and histopathological study of liver were also carried out. Metabolic function of liver was evaluated by thiopentone induced sleeping time. CCl4 administration produced a significant hepatotoxicity (P<0.001), which was reversed with K-Liv DS treatment. It significantly decreased transaminases, alkaline phosphatase and bilirubin and increased total proteins (P<0.001). Moreover oxidative stress was decreased and metabolic function was improved by decrease in sleeping time. Histopathological examination revealed no abnormalities in the K-Liv DS treated rats. K-Liv DS is an effective hepatoprotective agent and has potential clinical applications for liver diseases.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Present study investigates K-Liv DS, a polyherbal formulation on carbon tetrachloride induced hepatotoxicity in Wistar rats. Rats were divided into normal control, CCl4 control, CCl4+K-Liv DS (0.5 ml) and CCl4+K-LivDS (1 mL). CCl4 was injected intraperitoneally from day 1 to day 10, while K Liv DS was administered orally for 14 days. Hepatoprotective activity was assessed by estimating transaminases, alkaline phosphatase, total protein and bilirubin in serum. Estimation of oxidative stress markers and histopathological study of liver were also carried out. Metabolic function of liver was evaluated by thiopentone induced sleeping time. CCl4 administration produced a significant hepatotoxicity (P<0.001), which was reversed with K-Liv DS treatment. It significantly decreased transaminases, alkaline phosphatase and bilirubin and increased total proteins (P<0.001). Moreover oxidative stress was decreased and metabolic function was improved by decrease in sleeping time. Histopathological examination revealed no abnormalities in the K-Liv DS treated rats. K-Liv DS is an effective hepatoprotective agent and has potential clinical applications for liver diseases.
Key concepts: Carbon tetrachloride, Alkaline phosphatase, CCL4, Bilirubin, Oxidative stress, Liver function, Chemistry, Internal medicine